55 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
agreement, which restrictions may lapse separately or in combination at such time or times and on such terms, conditions and satisfaction … agreement are satisfied in the performance cycle, the determination of which satisfaction shall be made by the Board on the determination date. Unless
20-F/A
2019 FY
REPCF
Replicel Life Sciences Inc.
31 Mar 21
Annual report (foreign) (amended)
12:00am
agreement between us and the escrow agent. These common shares were to be released upon satisfaction of certain performance conditions as set out … agreement between RepliCel and the escrow agent. These shares are released upon satisfaction of certain performance conditions as set out in the escrow
6-K
EX-99.4
ja2lh5 wv5dx
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
1ehp3mzc
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
1ga71x7snto19vuh
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
xd51ahiguqjakkrx
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
qdbj6i e8rcwdczi
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
7iuh h8tj4aodle5jz
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
0cy9hnxysbwzju1qtnc
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.2
u3ypx
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
yo9xbv4 pr
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am